GPhA changes name to the Association for Accessible Medicines

Its new identity will improve recognition that the generic and biosimilar medicines industry is one of “the nation's great health care success stories, and that competition from generics and biosimilars lowers the cost of medicine.”

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

Login or Register to post a comment.